Mark Buller

913 total citations
12 papers, 684 citations indexed

About

Mark Buller is a scholar working on Virology, Infectious Diseases and Genetics. According to data from OpenAlex, Mark Buller has authored 12 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 6 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in Mark Buller's work include Poxvirus research and outbreaks (7 papers), Virus-based gene therapy research (6 papers) and Herpesvirus Infections and Treatments (4 papers). Mark Buller is often cited by papers focused on Poxvirus research and outbreaks (7 papers), Virus-based gene therapy research (6 papers) and Herpesvirus Infections and Treatments (4 papers). Mark Buller collaborates with scholars based in United States, Austria and United Kingdom. Mark Buller's co-authors include Claudius Vincenz, Vishva M. Dixit, Shimin Hu, Mike Bray, Scott Parker, Richard Weltzin, Jian Liu, Thomas P. Monath, Richard Nichols and Joan Fusco and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Clinical Infectious Diseases.

In The Last Decade

Mark Buller

12 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Buller United States	8	351	282	264	232	116	12	684
Junpeng Yan United States	12	378 1.1×	375 1.3×	194 0.7×	233 1.0×	60 0.5×	15	732
Spyridon Stavrou United States	15	342 1.0×	243 0.9×	146 0.6×	309 1.3×	63 0.5×	22	726
О. С. Таранов Russia	14	274 0.8×	178 0.6×	147 0.6×	133 0.6×	74 0.6×	76	552
Harriet C. T. Groom United Kingdom	11	576 1.6×	611 2.2×	286 1.1×	555 2.4×	133 1.1×	13	1.3k
Ilja Bontjer Netherlands	15	321 0.9×	353 1.3×	128 0.5×	256 1.1×	53 0.5×	31	735
Steven W. Granger United States	10	166 0.5×	182 0.6×	201 0.8×	319 1.4×	101 0.9×	18	602
Christina Ochsenbauer United States	2	318 0.9×	615 2.2×	192 0.7×	408 1.8×	47 0.4×	2	845
Matthias Hamdorf Germany	8	253 0.7×	195 0.7×	103 0.4×	207 0.9×	66 0.6×	12	537
Mary K. Short United States	13	330 0.9×	176 0.6×	123 0.5×	155 0.7×	119 1.0×	24	709
Michael L. Key United States	7	263 0.7×	113 0.4×	106 0.4×	331 1.4×	67 0.6×	8	646

Countries citing papers authored by Mark Buller

Since Specialization

Citations

This map shows the geographic impact of Mark Buller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Buller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Buller more than expected).

Fields of papers citing papers by Mark Buller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Buller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Buller. The network helps show where Mark Buller may publish in the future.

Co-authorship network of co-authors of Mark Buller

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Buller. A scholar is included among the top collaborators of Mark Buller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Buller. Mark Buller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Oliveira, Leonardo Camilo de, Jonas D. Albarnaz, Alice A. Torres, et al.. (2020). The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model. Archives of Virology. 165(3). 671–681. 13 indexed citations

Franceschi, Valentina, Scott Parker, Konstantin Doronin, et al.. (2015). BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge. PLoS neglected tropical diseases. 9(6). e0003850–e0003850. 42 indexed citations

Matho, Michael H., Xiangzhi Meng, Mohammed Rafii‐El‐Idrissi Benhnia, et al.. (2015). Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer. PLoS Pathogens. 11(9). e1005148–e1005148. 45 indexed citations

Kaever, Thomas, Xiangzhi Meng, Michael H. Matho, et al.. (2014). Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein. Journal of Virology. 88(19). 11339–11355. 39 indexed citations

Blazevic, Azra, et al.. (2013). Investigations of TB vaccine-induced mucosal protection in mice. Microbes and Infection. 16(1). 73–79. 7 indexed citations

Milner, Joshua D., Tatyana Orekov, Jerrold M. Ward, et al.. (2010). Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood. 116(14). 2476–2483. 90 indexed citations

Moise, Leonard, Matt Ardito, Jill Schriewer, et al.. (2009). Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice. 1(1). 15–22. 2 indexed citations

Buller, Mark, et al.. (2008). CMX001. Anti-smallpox agent, anti-cytomegalovirus agent, viral polymerase inhibitor. Drugs of the Future. 33(8). 655–655. 6 indexed citations

Painter, George R., Mark Buller, Earl R. Kern, et al.. (2006). The Challenges of Developing an Antiviral Agent for the Treatment of Smallpox Using the Animal Efficacy Rule. Future Virology. 1(2). 173–179. 1 indexed citations

10.

Bray, Mike & Mark Buller. (2004). Looking Back at Smallpox. Clinical Infectious Diseases. 38(6). 882–889. 48 indexed citations

11.

Monath, Thomas P., Wolfgang Mundt, Joan Fusco, et al.. (2004). ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense. International Journal of Infectious Diseases. 8. 31–44. 112 indexed citations

12.

Hu, Shimin, Claudius Vincenz, Mark Buller, & Vishva M. Dixit. (1997). A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis. Journal of Biological Chemistry. 272(15). 9621–9624. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact